Overview of VitalHub's Q3 Performance
VitalHub Corp. reported significant financial achievements for the third quarter of 2025. The company's Annual Recurring Revenue (ARR) saw a remarkable growth of 75% from the previous year, reaching $93.7 million. Alongside this, total revenue surged by 94% year-over-year, amounting to an impressive $32.0 million. Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) also increased substantially, showing a 58% rise to $7.2 million.
Key Financial Highlights
During the third quarter, VitalHub's ARR stood at approximately $93.69 million, a stark rise compared to $79.59 million in the preceding quarter, representing an increase of $14.10 million or 18%. This growth can be attributed to organic growth, which contributed $1.71 million, acquisition growth of $12 million, and a foreign exchange fluctuation gain of $393,373.
Performance Metrics
For the three months ending September 30, 2025, revenue reached $32.04 million, compared to $16.51 million in the same period last year, translating into a growth of $15.53 million or 94%. The gross profit margin remained stable at 81% in both Q3 2025 and Q3 2024. It is noteworthy that the net income before taxes fell to $1.59 million from $2.36 million a year ago, a decrease of 33%.
EBITDA reported for Q3 was $4.78 million, reflecting a 59% growth from $3.00 million in the previous year's third quarter. The Adjusted EBITDA hit $7.21 million, constituting 22% of total revenue, which is up from $4.55 million or 28% of revenue in the previous year.
Highlights from the Nine-Month Review
When examining the nine months ending September 30, 2025, VitalHub has accrued an ARR of $93.69 million, compared to $53.45 million the year prior, indicating a remarkable increase of 75%. This increase was driven by organic growth of $7.96 million and an impressive acquisition growth of $30.47 million, along with a foreign exchange gain of $1.81 million.
Comparative Revenue Analysis
For the entirety of the first nine months of 2025, total revenue was reported at $77.58 million, an increase of approximately $29.57 million or 62% from $48.00 million in the same period in 2024. The gross profit for these nine months remained robust at a consistent 81% across both years.
Net income before taxes for the nine-month period stood at $5.33 million, slightly lower than $5.72 million for the same duration in 2024. The company reported a notable EBITDA of $11.53 million for the nine months of 2025, a 43% increase from $8.08 million the previous year. The Adjusted EBITDA came in at $19.13 million, marking a growth of 49% from the previous year’s total of $12.79 million.
Cash Flow and Future Outlook
As of September 30, 2025, VitalHub reported cash on hand of $123.68 million, a substantial increase from $56.57 million at the end of the previous year. This robust cash position supports the company's strategy of continuing investments in organic growth and further acquisitions to enhance market presence and product offerings.
Strategic Initiatives
VitalHub’s focus on both organic growth and strategic acquisitions positions the company well for future expansion in the competitive healthcare technology sector. The integration of recent acquisitions and the continuous enhancement of their product suite reflect their commitment to strengthening their market stance and boosting operational efficiencies.
Frequently Asked Questions
What are the key financial achievements of VitalHub in Q3 2025?
VitalHub reported a 75% increase in ARR, with revenue growth of 94% year-over-year, reaching $32 million.
How does VitalHub's financial position support its future growth?
The company has a strong cash position of $123.68 million, enabling continued investments in growth strategies and potential acquisitions.
What strategic initiatives is VitalHub pursuing?
VitalHub is focusing on organic growth along with strategic acquisitions to enhance its product offerings and market reach.
What was the Adjusted EBITDA reported for Q3 2025?
VitalHub reported an Adjusted EBITDA of $7.21 million, which is 22% of total revenue.
Who can be contacted for further information regarding VitalHub?
Christian Sgro, the Head of IR and M&A Specialist, can be contacted at (365) 363-6433 or by email at christian.sgro@vitalhub.com.
